SOLSTICE CAPITAL
Solstice Capital seeks superior venture capital returns for its limited partners through investments in seed- and early-stage companies in the industry areas of alternative energy, education, the environment, life sciences and information technology. Solstice's unique assets give it a distinct advantage: a seasoned management team with over 90 years of experience in both venture investing and operations in high-growth companies an emphasis on positive impact investing the appropriate siz... e fund for early-stage companies geographic diversification From its inception, Solstice has demonstrated its commitment to provide both capital and expert guidance to assist portfolio companies as they deal with the challenges and opportunities of growth. An early-stage, diversified, positive impact venture fund Solstice is committed to investing 50% of its capital in information technology and 50% in the following socially responsive investment categories: Alternative Energy The Environment Life Sciences Education
SOLSTICE CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
1995-01-01
Status:
Active
Contact:
(617) 523-7733
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Analytics Google Universal Analytics Nginx PHP Network Solutions DNS Rackspace Intermedia Nginx 1.8 Newfangled CMS
Similar Organizations
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-05-21 | Splash Pharmaceuticals | Solstice Capital investment in Series D - Splash Pharmaceuticals | N/A |
| 2011-07-13 | HTG Molecular Diagnostics | Solstice Capital investment in Series D - HTG Molecular Diagnostics | 16.2 M USD |
| 2011-06-06 | Regenesis Biomedical | Solstice Capital investment in Series C - Regenesis Biomedical | 5.3 M USD |
| 2008-11-28 | HTG Molecular Diagnostics | Solstice Capital investment in Series C - HTG Molecular Diagnostics | 2.8 M USD |
| 2008-11-14 | CodeRyte | Solstice Capital investment in Series D - CodeRyte | 13 M USD |
| 2008-05-22 | Regenesis Biomedical | Solstice Capital investment in Series B - Regenesis Biomedical | 2.79 M USD |
| 2008-01-29 | Lumidigm | Solstice Capital investment in Series C - Lumidigm | 7 M USD |
| 2008-01-14 | AmpliMed Corporation | Solstice Capital investment in Series C - AmpliMed Corporation | 5 M USD |
| 2007-10-08 | HTG Molecular Diagnostics | Solstice Capital investment in Series C - HTG Molecular Diagnostics | 5.62 M USD |
| 2007-03-05 | Arxan Technologies | Solstice Capital investment in Series C - Arxan Technologies | 13 M USD |